$SIBN

Davis Timothy E JR sold $49K of SIBN

Davis Timothy E JR sold 3,500 shares of SI-BONE, Inc. (SIBN) at $14.14 on 2026-05-29.

Original reporting
SEC EDGAR · Davis Timothy E JR
Published Jun 1, 2026, 9:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SIBN
Neutral
low confidence
Mentioned
$SIBN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The disclosure updates insider ownership/flow information; it may slightly affect sentiment but does not introduce new operating or financial fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

The article provides only one director sale; without context on total insider activity, option exercises, or prior holdings changes, directional inference is weak.

Relevance 6/10Novelty 6/10Timing: Filed June 1; sale occurred May 29.

Background

The article is an SEC Form 4 insider transaction disclosure for SI-BONE, Inc.

Company-level read

Ticker impact

$SIBNNeutralLow confidence
Context

SI-BONE director Timothy E. Davis sold 3,500 shares in an open-market transaction for ~$49.5K, disclosed via Form 4.

Expected impact

Low near-term impact; any effect is likely sentiment-driven and short-lived.

Evidence & confidence

The filing is a routine insider transaction with limited size detail and no accompanying fundamental catalyst (earnings, guidance, deal, or investigation).

Market effects

Minimal; this is company-specific insider activity with no sector-wide read-through stated.

None indicated.

None indicated.

Counterpoint

A non-10b5-1 sale may reflect diversification or personal liquidity needs rather than negative expectations.

Key entities

  • SI-BONE, Inc.

    Subject of the Form 4 insider transaction; director sold shares on May 29.

  • Timothy E. Davis Jr.

    Director who executed the open-market sale; not on a pre-arranged 10b5-1 plan.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q